← Back to Search

Focused Ultrasound

Neuro Ablation - Functional for Epilepsy (EP001 Trial)

N/A

Recruiting

Led By Nathan Fountain, MD

Research Sponsored by InSightec

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at the time of exablate transcranial procedure

Awards & highlights

EP001 Trial Summary

This trial is testing whether a new brain surgery to treat epilepsy is safe and effective.

Eligible Conditions

Epilepsy

EP001 Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at the time of exablate transcranial procedure

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at the time of exablate transcranial procedure

This trial's timeline: 3 weeks for screening, Varies for treatment, and at the time of exablate transcranial procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Incidence and severity of device and procedure related complications

EP001 Trial Design

1Treatment groups

Experimental Treatment

Group I: Exablate Neuro System TreatmentExperimental Treatment1 Intervention

MR-Guided Focused Ultrasound will be used to ablate epileptic foci up to 8 cm3 in size.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

InSightecLead Sponsor

88 Previous Clinical Trials

3,684 Total Patients Enrolled

1 Trials studying Epilepsy

20 Patients Enrolled for Epilepsy

Food and Drug Administration (FDA)FED

171 Previous Clinical Trials

1,331,586 Total Patients Enrolled

3 Trials studying Epilepsy

72 Patients Enrolled for Epilepsy

Nathan Fountain, MDPrincipal InvestigatorUniversity of Virginia

1 Previous Clinical Trials

240 Total Patients Enrolled

1 Trials studying Epilepsy

240 Patients Enrolled for Epilepsy

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To whom is enrollment in this medical study available?

"Qualifying participants for this research must be aged between 18 and 80, have a medical diagnosis of gelastic epilepsy, and the study is seeking to enroll 20 patients."

Answered by AI

Can individuals under the age of sixty participate in this research?

"This research is seeking participants who are 18 years and over, but not yet 80."

Answered by AI

What is the current scope of this clinical trial's implementation?

"At the moment, 5 different medical sites are running this trial; three of them being Rochester, Kansas City and Charlottesville with two other cities hosting. It is advisable to choose the closest location in order to reduce travelling obligations if you join."

Answered by AI

How many participants are eligible to join this research program?

"InSightec, the sponsor of this trial, needs a total of 20 eligible participants to initiate the study. For their convenience, InSightec has established sites at Mayo Clinic in Rochester, Minnesota and Stanford University Medical Center in Kansas City, Kansas."

Answered by AI

Are there any vacancies for this clinical experiment?

"Affirmative. Information gathered from clinicaltrials.gov reveals that this investigation, which was initially listed on June 7th 2016, is actively recruiting volunteers. Twenty individuals are expected to be enrolled at 5 medical centres."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

MR-Guided Focused Ultrasound in the Treatment of Focal Epilepsy (EP001)

2016. "MR-Guided Focused Ultrasound in the Treatment of Focal Epilepsy (EP001)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02804230.

All > Focal Epilepsy